Variable Total Retained in care 6-month attrition Total Retained in care 12-month attrition
Sex            
Female 349 312 (89.4) 37 (10.6) 345 292 (84.6) 53 (15.4)
Male 186 149 (80.1) 37 (19.9) 182 139 (76.4) 43 (23.6)
Age (years)            
<30 99 85 (85.9) 14 (14.1) 97 79 (81.4) 18 (18.6)
30-39 273 235 (86.1) 38 (13.9) 269 221 (82.2) 48 (17.8)
40-49 120 106 (88.3) 14 (11.7) 118 99 (83.9) 19 (16.1)
≥50 43 35 (81.4) 8 (18.6) 43 32 (74.4) 11 (25.6)
Baseline CD4 count (cells/mm3)        
<100 163 123 (75.5) 40 (24.5) 159 118 (74.2) 41 (25.8)
≥100 367 334 (91.0) 33 (9.0) 363 309 (85.1) 54 (14.9)
Intervention            
control 263 222 (84.4) 41 (15.6) 262 209 (79.8) 53 (20.2)
intervention 272 239 (87.9) 33 (12.1) 265 222 (83.8) 43 (16.2)
Travel time to clinic          
≤30 minutes 190 166 (87.4) 24 (12.6) 186 157 (84.4) 29 (15.6)
31-60 minutes 179 156 (87.2) 23 (12.8) 176 147 (83.5) 29 (16.5)
61-120 minutes 129 108 (83.7) 21 (16.3) 128 101 (78.9) 27 (21.1)
>120 minutes 36 30 (83.3) 6 (16.7) 36 25 (69.4) 11 (30.6)
HIV disclosure at baseline        
 Disclosed 455 393 (86.4) 62 (13.6) 447 369 (82.6) 78 (17.4)
 Not disclosed 80 68 (85.0) 12 (15.0) 80 62 (77.5) 18 (22.5)
Table 1: Retention of participants at 6 and 12 months after ART initiation, by sociodemographic and clinical characteristics